Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Michael
AddedMar 31, 2024
UpdatedMay 31, 2026
David Michael

David Michael

Board Member, Pivotal Systems

CrunchbaseLinkedIn

David Michael's Career

Pivotal Systems
Pivotal Systems

Fremont, CA, US

Board Member· Board
BioSkryb Genomics
BioSkryb Genomics

Durham, NC, US

Board Member· Board
Niron Magnetics
Niron Magnetics

Minneapolis, MN, US

Board Member· Board
TeraPore Technologies
TeraPore Technologies

South San Francisco, CA, US

Board Member· Board
6K
6K

North Andover, MA, US

Board Member· Board
InterVenn Biosciences
InterVenn Biosciences

Dover, DE, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Michael's Career

Pivotal Systems
Pivotal Systems
Public$48.9M302003Fremont, CA, US
Board Member· Board

Leadership at Pivotal Systems

Kevin M. HillKevin M. HillCEO
Kevin LandisKevin LandisBoard Member
Sherk ChungSherk ChungFounder
Carl EiblCarl EiblBoard Member
Joe MonkowskiJoe MonkowskiBoard Member
Jason KormanJason KormanBoard Member
BioSkryb Genomics
BioSkryb Genomics
Series A$31.5M832018Durham, NC, US
Board Member· Board

Leadership at BioSkryb Genomics

Suresh PisharodySuresh PisharodyCEO
Jay WestJay WestCo-Founder
Charles GawadCharles GawadBoard Member

Similar to BioSkryb Genomics

Singular GenomicsSingular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134
Scribe BiosciencesScribe BiosciencesSan Francisco, CA, USBiotechest. 2017Scribe BiosciencesSan Francisco, CA, US · est. 2017

Scribe Biosciences: Pioneering tech for immunotherapy discoveries via single-cell profiling.

Seed · $3.1M7
Streamline GenomicsStreamline GenomicsMontreal, Quebec, CAGenomic Analysisest. 2017Streamline GenomicsMontreal, Quebec, CA · est. 2017

Streamline Genomics: Simplifying genomic sequencing with an easy-to-use platform for clinicians and researchers.

Seed · $120k2
Data Driven BioscienceData Driven BioscienceDurham, NC, USGenomic Toolsest. 2018Data Driven BioscienceDurham, NC, US · est. 2018

Data-driven biotech firm providing genomic tools for cancer diagnosis and treatment in clinical labs.

Seed · $120k30
Niron Magnetics
Niron Magnetics
Series C$84.6M612014Minneapolis, MN, US
Board Member· Board

Leadership at Niron Magnetics

Jian WangJian WangFounder
Jimmy KanJimmy KanBoard Member
Jonathan RowntreeJonathan RowntreeCEO

Similar to Niron Magnetics

CorePower MagneticsCorePower MagneticsPittsburgh, PA, USInductors, Magnetic Coresest. 2020CorePower MagneticsPittsburgh, PA, US · est. 2020

CorePower Magnetics custom-engineers magnetic cores for advanced power systems, enhancing efficiency, power density, and longevity.

Series B · $27.5M8
Correlated Magnetics ResearchCorrelated Magnetics ResearchHuntsville, AL, USMagnetic Materials, Magnetic Systemsest. 2008Correlated Magnetics ResearchHuntsville, AL, US · est. 2008

Correlated Magnetics Research: Innovating in correlated magnetic structures R&D.

Series A · $10.5M11
Advanced Magnet LabAdvanced Magnet LabPalm Bay, FL, USMagnets, Magnet Systemsest. 1995Advanced Magnet LabPalm Bay, FL, US · est. 1995

Advanced Magnet Lab Inc: Specializing in the design and production of advanced magnet-based applications.

Series A · $2.9M49
Magnum MagneticsMagnum MagneticsMarietta, OH, USMagnetic Productsest. 1991Magnum MagneticsMarietta, OH, US · est. 1991

Magnum Magnetics crafts flexible, customizable magnets for commercial printing, signage, and retail industries.

Series A · $12.3M251
TeraPore Technologies
TeraPore Technologies
Series A$17.7M262013South San Francisco, CA, US
Board Member· Board

Leadership at TeraPore Technologies

Rachel DorinRachel DorinFounder
David SeldinDavid SeldinBoard Member
Jean-Paul MangeolleJean-Paul MangeolleBoard Member
6K
6K
Series D$233.3M2182014North Andover, MA, US
Board Member· Board

Leadership at 6K

Adam SharkawyAdam SharkawyBoard Member
Aaron BentAaron BentCEO
Konstantine DrakonakisKonstantine DrakonakisBoard Member
InterVenn Biosciences
InterVenn Biosciences
Series C$278.1M1552017Dover, DE, US
Board Member· Board

Leadership at InterVenn Biosciences

Aldo CarrascosoAldo CarrascosoCo-Founder
Joshua StahlJoshua StahlCEO
Giulia C. KennedyGiulia C. KennedyBoard Member
Carlito LebrillaCarlito LebrillaCo-Founder
Lieza DananLieza DananCo-Founder
Paul BreesPaul BreesBoard Member

David Michael's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to David Michael

Mike KleinMike KleinBoard Member · IcadPatrick HeimPatrick HeimBoard Member · PreemptGreg DraconGreg DraconBoard Member · TausightSalil PunalekarSalil PunalekarBoard Member · ScienapticMichael HubbardMichael HubbardBoard Member · WalkMeGilad GlickGilad GlickBoard Member · Beta Bionics